Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
45.8M
-
Shares change
-
+4.93M
-
Total reported value, excl. options
-
$114M
-
Value change
-
+$11.8M
-
Put/Call ratio
-
2.92
-
Number of buys
-
42
-
Number of sells
-
-24
-
Price
-
$2.50
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2019
82 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q2 2019.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.8M shares
.
Largest 10 shareholders include NEA Management Company, LLC (5.72M shares), Vivo Capital, LLC (5.68M shares), PERCEPTIVE ADVISORS LLC (4.4M shares), BlackRock Inc. (3.65M shares), BOXER CAPITAL, LLC (2.91M shares), VANGUARD GROUP INC (2.85M shares), RENAISSANCE TECHNOLOGIES LLC (2.57M shares), BVF INC/IL (2.22M shares), CAXTON CORP (2.1M shares), and MILLENNIUM MANAGEMENT LLC (1.59M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.